Sort
261,768 grants matching “gene therapy”
Clinical Pharmacogenetics
$966,995William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Neonatal Porcine Islet Xenografts for the Treatment of Type 1 Diabetes
$966,935Allan D. Kirk · Emory University · U01 · FY2010 · AI
PRESERVATION AND REPLACEMENT OF BETA CELLS IN IDDM
$966,934Yeshiva University · P01 · FY2001 · DK
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$966,899Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Epigenetic plasticity in tumor initiation and evolution
$966,868Bradley E Bernstein · Massachusetts General Hospital · DP1 · FY2020 · CA
Initiation of DNA Replication in Mammalian Cells
$966,780Mirit Aladjem · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
NIMH Non-Human Primate Research Core
$966,701James Winslow · National Institute Of Mental Health · Z01 · FY2007 · MH
Developmental Core
$966,667Bruce D. Rapkin · Sloan-Kettering Inst Can Research · U54 · FY2011 · CA
Optimizing eCD4-Ig for eradication and a functional cure
$966,508Michael R. Farzan · Scripps Florida · R01 · FY2017 · AI
MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM
$966,492Balazs Halmos · Montefiore Medical Center (Bronx, Ny) · UG1 · FY2022 · CA
Multi-organ metastatic breast cancer cell-based assay platform that models organotropic metastases using patient organoids in human tissue-derived ECMs to accelerate anti-metastatic drug development
$966,420John David O'Neill · Xylyx Bio, Inc. · R44 · FY2025 · CA
Immunobiology and therapy of oral mucosal and salivary gland chronic graft-versus-host disease
$966,385Jacqueline Mays · National Institute Of Dental & Craniofacial Research · ZIA · FY2016 · DE
Program to promote lung regeneration and block fibrosis
$966,372Harold A Chapman · University Of California, San Francisco · R35 · FY2025 · HL
Combination Immunotherapy of a Novel Superagonist IL-15 Complex and Anti-CD20 Antibody for Indolent Non-Hodgkin Lymphoma
$966,343Hing C. Wong · Altor Bioscience. Llc · R44 · FY2016 · CA
Safety and Tolerability Studies for an Anti-Fibrin P2 Monoclonal Antibody for the Treatment of Alzheimer's Disease
$966,254Aaron B Kantor · Therini Bio, Inc. · U01 · FY2023 · AG
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant Infections
$966,226Victor Nizet · University Of California, San Diego · R01 · FY2015 · AI
Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation
$966,201William R Clarke · Xlock Biosciences, Llc · R44 · FY2024 · AR
Biology and genetics of metastatic disease
$966,151Sohail F. Tavazoie · Rockefeller University · R35 · FY2024 · CA
Novel Involvement of eNAMPT/TLR4 Signaling in PAH Vascular Remodeling and Right Ventricular Dysfunction
$965,998Joe G. N. Garcia · University Of Florida · R01 · FY2025 · HL
Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory Diseases
$965,908Daniel Kastner · National Human Genome Research Institute · ZIA · FY2013 · HG
Reprogramming of T cells for the Treatment of Melanoma
$965,794Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Biology of the Lung: A Multidisciplinary Program
$965,792David M Center · Boston University Medical Campus · T32 · FY2011 · HL
Targeting the MYC Pathway for the Treatment of Cancer
$965,767Dean W Felsher · Stanford University · R35 · FY2025 · CA
IRIS: Incorporating Research Into Sight
$965,749Catherine Anne McCarty · Essentia Institute Of Rural Health · U01 · FY2014 · HG
Project 4: Cross-species Dissection of Cellular Response to APOE Genotype and AD Pathology Using Single-cell Multi-omics
$965,724Michael Ryan Corces · J. David Gladstone Institutes · P01 · FY2021 · AG